Pharma Portfolio & Product Life Cycle Management 2013

R&D prices are skyrocketing ever higher, whilst the drug development industry feels the squeeze of the recession. With this ever-increasing need to ensure a cost-effective and efficient portfolio, the planning and preparation for each drug portfolio must be optimised to provide the maximum revenue for the minimum expenditure.

Expert speakers will explore and debate the key success factors for portfolio planning and lifecycle management, including risk assessment, effective decision making, market exclusivity and innovation of products in pharma.

This is the 8th conference in this winning annual series and we are certain it will be the best yet! With 20 expert speakers, 17 in-depth presentations and two interactive half-day workshops this will be the one conference in 2013 to attend for the very latest intelligence to help you develop winning strategies in an increasingly challenging marketplace.

Featured Speakers

Kimber Hardy

Lucette Doessegger

Michel Hamende

Richard Fazackerley

Tom Halliwell

Benefits of Attending

• Discover current and cutting-edge methods of portfolio management

• Determine how to increase efficiency of a drug lifecycle in order to create a drug with minimum cost and maximum revenue

• Explore drug pricing and profit: how to read the market to benchmark the appropriate cost of a drug

• Learn about the emerging markets in the industry and how this leads to new drug discoveries, as well as which sectors are becoming increasingly important in drug research and discovery

• Debate lifecycle management techniques and best practices for drug development, including prioritisation, optimisation and management of a drug development portfolio

• Examine the best analysis techniques, which programs to use, and which methods will gain the most accurate and useful results